Evaluation of Phytochemical Constituents, Antibacterial Activities and Effect of Exudate of Pycanthus Angolensis Weld Warb (Myristicaceae) on Corneal Ulcers in Rabbits
Purpose: A 1: 1: 2 mixture of exudates of Anchomonas difformis, Cyrtrospherma senegalense and Pycanthus angolensis is claimed to be used for the treatment of corneal ulcers. The purpose of the study is to evaluate the phytochemical constituents, antibacterial activities and the effectiveness of a mixture of these exudates in the treatment of corneal ulcers as claimed in Traditional medicine practice. Method: Fresh exudates were collected in different containers. They were reduced to dryness and each residue tested for phytochemical constituents. Exudates of P. angolensis was further tested for antimicrobial activities and its effect on chemical – induced corneal ulcers in rabbits. Result: Only reducing sugars were detected in exudates of A. angolensis and C. senegalensis. Bioactive constituents detected in exudates of P. angolensis were the reducing sugars and phenolic compounds- tannins and flavonoids. This also showed antimicrobial activity against the organisms used. It healed the NaOH – induced corneal ulcers in rabbits within ten of days of treatment. Conclusion: Exudates of P.angolensis contained bioactive constituents and exhibited antibacterial activity, and healed the corneal ulcers induced in rabbits. Its use in traditional practice for healing corneal ulcers is rational, even in the absence of exudates of A. angolensis and C. senegalensis.
Keywords: Pycanthus angolensis, exudates, corneal ulcers, rabbits.
> Tropical Journal of Pharmaceutical Research Vol. 6 (2) 2007: pp. 725-730
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.